Wesper Journal

Why Is Wesper Poised to Change Sleep Medicine Alongside a GLP-1
Wesper is poised to change sleep medicine alongside GLP-1 by integrating advanced sleep monitoring technology with GLP-1 therapies, enabling comprehensive and personalized treatment for sleep apnea. This combination offers real-time treatment optimization and enhanced patient outcomes, marking a significant advancement...
Continue reading
Living with ADHD and Sleep Apnea: Experiences Shared
Many individuals with ADHD also experience sleep apnea, which exacerbates ADHD symptoms but can be significantly alleviated through CPAP therapy and lifestyle modifications. Personal stories highlight the transformative impact of treatment, leading to improved focus, energy, and overall well-being. 1....
Continue reading
CPAP Sleep Relieves Brain Fog After First Night
Many people experience immediate mental clarity and reduced brain fog after just one night of using CPAP therapy, as it alleviates airway obstruction and enhances sleep quality. The therapy delivers consistent airway support, leading to improved oxygen levels and restorative...
Continue reading
Revolutionizing Sleep Apnea Diagnosis and Management:  The Power of Wesper + Impilo
Impilo and Wesper are revolutionizing sleep apnea diagnosis and management by combining Remote Patient Monitoring (RPM) with advanced at-home sleep testing. Traditional sleep studies are cumbersome, but Impilo’s seamless device integration enables real-time health tracking, while Wesper’s wireless biometric patches provide high-resolution sleep data without intrusive equipment. This powerful integration allows for early detection, personalized treatment adjustments, and increased patient engagement , ensuring more accurate diagnoses and better long-term outcomes. By leveraging cutting-edge technology, Impilo and Wesper are making sleep apnea care more accessible, precise, and proactive —empowering patients to take control of their sleep health.
Continue reading
Transforming Sleep and Metabolic Health with GLP-1 Medications
Discover how Zepbound® (tirzepatide), the first FDA-approved medication for obstructive sleep apnea (OSA) in adults with obesity, is revolutionizing treatment. Combining effective weight management with symptom relief, Zepbound offers a groundbreaking solution that enhances sleep quality, simplifies care pathways, and improves overall health outcomes. Learn more about this transformative advancement in OSA therapy.
Continue reading

our research

The Wesper Journal is our weekly publication dedicated to exploring sleep apnea, sleep health, and the latest updates from Wesper. Each edition offers expert insights, practical tips, and valuable resources to help you better understand and improve your sleep, empowering you to take control of your sleep health journey.